Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGSWW) Interest Expenses (2020 - 2023)

GeneDx Holdings has reported Interest Expenses over the past 4 years, most recently at $626000.0 for Q2 2023.

  • Quarterly results put Interest Expenses at $626000.0 for Q2 2023, down 20.76% from a year ago — trailing twelve months through Mar 2024 was $626000.0 (down 80.23% YoY), and the annual figure for FY2022 was $3.2 million, up 13.12%.
  • Interest Expenses for Q2 2023 was $626000.0 at GeneDx Holdings, down from $767000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for WGSWW hit a ceiling of $808000.0 in Q1 2022 and a floor of $626000.0 in Q2 2023.
  • Median Interest Expenses over the past 4 years was $722500.0 (2021), compared with a mean of $726666.7.
  • Biggest five-year swings in Interest Expenses: increased 18.01% in 2022 and later fell 20.76% in 2023.
  • GeneDx Holdings' Interest Expenses stood at $648000.0 in 2020, then grew by 9.1% to $707000.0 in 2021, then rose by 13.58% to $803000.0 in 2022, then fell by 22.04% to $626000.0 in 2023.
  • The last three reported values for Interest Expenses were $626000.0 (Q2 2023), $767000.0 (Q1 2023), and $803000.0 (Q4 2022) per Business Quant data.